Clinical Chemistry Podcast
Clopidogrel and CYP2C19: Pharmacogenetic Testing Ready for Clinical Prime Time?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:11
- Mas informaciones
Informações:
Sinopsis
For patients with acute coronary syndrome who have undergone interventions such as placement of a stent, it has become standard practice to treat them with a combination of aspirin and opidogrel to prevent subsequent thrombotic events; however, clopidogrel is a drug that requires activation by a liver enzyme, CYP2C19.